Free Trial

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$7.04 +0.13 (+1.88%)
Closing price 03:58 PM Eastern
Extended Trading
$7.00 -0.04 (-0.57%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/31/2025
8:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:15 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2025
3:19 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/02/2025
4:24 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/30/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
4:59 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
05/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
7:31 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
04/29/2025
3:15 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/17/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:41 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
Get This Stock Now (Ad)

This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.

Get my full take on this exciting play right here…
01/21/2025
5:24 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Click here to see the Tesla shock that could blindside everyone.
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BDRX) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners